Recent proposals from the U.S. Food and Drug Administration (FDA) to expand disclosure requirements in drug ads could overwhelm patients and families and make information harder to use, writes Laura Bonnell in 535.news.
Recent proposals from the U.S. Food and Drug Administration (FDA) to expand disclosure requirements in drug ads could overwhelm patients and families and make information harder to use, writes Laura Bonnell in 535.news.